Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia

N/ACompletedNCT02175693

Eisai Co., Ltd.1,647 enrolled

Overview

Investigation of the clinical condition and safety in patients with cervical dystonia

Study Type

OBSERVATIONAL

Enrollment

1,647

Conditions

Cervical Dystonia

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion criteria: Patients with cervical dystonia Exclusion criteria: The patients who participated in this surveillance in the past

Locations (2)

Unnamed facility

Osaka, Japan

Unnamed facility

Tokyo, Japan

Outcomes

Primary Outcomes

Overall assessments of the improvement in the seriousness of seizures

Improvement is based on the 5 following elements: 1) Eminent improvement 2) Improvement 3) Improvement a little invariability 5) Exacerbation 6) It is not possible to judge

Time frame: Up to 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.